Gender Comparison Of Alpha-Fetoprotein, CD4, Albumin and Some Liver Enzymes in Symptomatic HIV Subjects on Antiretroviral Therapy
The emergence of Human Immunodeficiency Virus (HIV) has remained an issue of global discuss till date as it continues to invade and ravage the world’s population despite the efforts been made globally at tackling the impact of the virus. This is a case controlled study designed to comparatively evaluate the alpha-fetoprotein, CD4+ T-cell count, albumin and some liver enzymes activities in male and female symptomatic HIV subjects on antiretroviral therapy in NAUTH Nnewi, South Eastern Nigeria. A total of seventy one (71) participants who were aged between 18 and 60 years attending the voluntary counseling and testing unit (VCT) and antiretroviral therapy unit (ART) of Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi as well as 25 control subjects were randomly recruited for the study . CD4 count, alpha fetoprotein (AFP), albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase activities were estimated by standard laboratory methods. Results showed no significant differences in the mean values of AFP, CD4 count, albumin, ALT, AST and ALP compared between male and female symptomatic HIV infected individuals on ART and symptomatic HIV infected male and female subjects NOT on ART (p>0.05) respectively. Also, there was no significant difference in ALT and AST activities when compared between male and female HIV seronegative control (p>0.05) although ALP activity was significantly higher in female control subjects than in males (p=0.01). This revealed no gender specific differences in mean values of alpha fetoprotein, albumin, CD4 T-cell count, and liver enzyme activities between male and female HIV infected symptomatic individuals on antiretroviral therapy and symptomatic HIV infected persons NOT on antiretroviral therapy.
2. UNAIDS. 2020 Global AIDS Update: Seizing the Moment; July 2020. UNAIDS. AIDS info Available at: http://aidsinfo.unaids.org/. UNAIDS. Core Epidemiology Slides; July 2020. Retrieved May, 2021.
3. Klatt EC, Pathology of AIDS version 25, Mercer University School of Medicine, Savannah, 2014.
4. Agosto LM, Zhong P, Munro J, Mothes W, PLOS Pathog. 2014; 10:2.
5. Ezeugwunne IP, Onyenekwe CC, Ogbodo EC, Chukwuanukwu RC, Njoku-Oji NN, Analike RA, Oguaka VN, Amah AK, Ahaneku JE, Ahaneku G. The impact of HIV and malaria co-infection on apolipoprotein profile and CD4+ T cell counts in adult HIV seropositives in Nauth Nnewi, South Eastern, Nigeria. Int. J. Curr. Res. Med. Sci. 2018; 4(3): 53-63.
6. Lane. Topics in HIV Medicine 2010; 18(1), 2-6.
7. Deeks S, Overbaugh J, Phillips A. HIV infection. Nat Rev Dis Primers 2015; 1:15035. https://doi.org/10.1038/nrdp.2015.35
8. Ezeugwunne IP, Ogbodo EC, Analike RA, Obi-Ezeani CN, Onuora IJ, Oguaka VN, Amah UK, Ugwu MC, Onyenekwe CC, Ahaneku JE. Serum Reproductive hormone levels in male symptomatic HIV/AIDS patients on Antiretroviral therapy negative to Malaria parasite in Nnewi, Anambra State, Nigeria. Asian J Med Sci 2019; 10(3):44-49.
9. Ezeugwunne IP, Ogbodo EC, Analike RA, Ifeanyichukwu M, Ogah HGO, Amah AK, Obi-Ezeani CN, Onyenekwe CC, Ahaneku JE, Meludu SC. Evaluation of Apolipoprotein and Lipid Profiles in HIV Symptomatic Subjects Before and After 12 Months Antiretroviral Therapy in NAUTH Nnewi, South Eastern Nigeria. J Med Laboratory Sci 2019; 29 (1): 52-60.
10. Danjuma MI, Shokri SAI, Bakhsh N, Alamin MA, Mohamedali MGH, Mohamedali GHM, Tamuno I. The utility of kidney injury molecule-1 as an early biomarker of kidney injury in people living with HIV. International Journal of STD and AIDS 2020; 31(13):1228–1237.
11. Johnkennedy N, Tecla D, Ukamaka E. (2020). Alterations of alpha fetoprotein and some liver enzymes, in HIV patients undergoing antiretroviral therapy at Federal Medical Centre, Owerri. Journal of Progressive Research in Biology; 4(1):12-18.
12. Ezeugwunne IP, Ogbodo EC, Analike RA, Okwara NA, Nnamdi JC, Iwuji JC, Obi-Ezeani CN, Amah AK, Odumodu IO, Onyenekwe CC. The pattern of alpha-fetoprotein, CD4+ count, albumin, AST, ALT and ALP in HIV subjects on long term antiretroviral therapy in Nauth Nnewi, Anambra State, Nigeria. Indian J Forensic Community Med 2021;8(1):45-51.
13. Doumas B, Watson W. The determination of serum albumin using Bromocresol Green (BCG). Clinica Chimica Acta 1971; 31:87-89.
14. Reitman S, Frankel SA. Colorimetric method for aspartate and alanine aminotransferases in serum. American J Clin Pathol 1957; 28:56-63.
15. Bessey OA, Lowry OH, Brock MJ. One point colorimetric method of determining alkaline phosphatase in serum or plasma. J Biol Chem 1946; 164:3217.
16. Naz Z, Usman S, Saleem K, Ahmed S, Bashir H, Bilal M, Sumrin A. Alpha-fetoprotein: A fabulous biomarker in hepatocellular, gastric and rectal cancer diagnosis. Biomed Res. 2018; 29(12): 2478-2483.
17. Ruoslahti E, Seppala M. α-Foetoprotein in normal human serum. Nature. 1972; 235:161–162.
18. Terentiev AA, Moldogazieva NT. Alpha-fetoprotein: a renaissance. Tumor Biol. 2013; 34:2075–2091.
19. Atiba AS, Akande JO, Niran-Atib TA, Daramola AO, Oparinde DP. Treatment Duration with Antiretroviral Therapy and Selected Liver Enzymes among HIV Positive Patients. Asian J Sci Res. 2021;14:24–31.
Copyright (c) 2021 Journal of Progressive Research in Biology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
JPRB is pleased to undertake the publication of your contribution to Journal of Progressive Research in Biology.
The copyright to this article is transferred to JPRB(including without limitation, the right to publish the work in whole or in part in any and all forms of media, now or hereafter known) effective if and when the article is accepted for publication thus granting JPRB all rights for the work so that both parties may be protected from the consequences of unauthorized use.